Physician

Matthew Dacunha, MD

According to 2025 Medicare claims, Matthew Dacunha, MD (NPI: 1659833622) practices dermatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is EPIPHANY DERMATOLOGY OF KANSAS, LLC (NPI: 1710444500; TIN: 833585324) and primary practice location at 66210-1836.

Dacunha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 491 traditional Medicare patients, billed 4,285 HCPCS/CPT codes, and received $211,599 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 373 prescription claims across 231 beneficiaries totaling $6,562 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 21 records totaling $461. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,282 to $6,562. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	319	1,527	$102,746
2024	491	4,285	$211,599

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	23	80	$5,282
2020	117	374	$126,724
2021	167	660	$646,370
2022	124	418	$420,846
2023	222	492	$452,965
2024	231	373	$6,562

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	99	110	$375
11102	Biopsy of related skin growth, first growth	128	140	$58
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	190	196	$44
17000	Destruction of precancer skin growth, 1 growth	181	194	$32
17003	Destruction of precancer skin growth, 2-14 growths	135	715	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	13	430	$933
Ketoconazole	Ketoconazole	38	1,128	$732
Triamcinolone Acetonide	Triamcinolone Acetonide	37	1,780	$532
Fluocinonide	Fluocinonide	16	430	$507
Doxycycline Hyclate	Doxycycline Hyclate	31	646	$341

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$461	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Dacunha, MD?

Tedicare shows public-source Medicare data for Matthew Dacunha, MD (NPI 1659833622), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Dacunha, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Dacunha, MD?

Matthew Dacunha, MD is linked to EPIPHANY DERMATOLOGY OF KANSAS, LLC (billing NPI 1710444500) in the available physician profile data.

Does Matthew Dacunha, MD have Open Payments data?

Matthew Dacunha, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.